Why the study?
Is baseline TAPSE/PASP ratio associated with all-cause mortality in patients undergoing TAVI?
Is baseline TAPSE/PASP ratio associated with all-cause mortality in patients undergoing TAVI?
Incorporating the TAPSE/PASP ratio into risk stratification may improve patient selection for TAVI by evaluating RV systolic performance against afterload.
Baseline TAPSE/PASP ratio is associated with all-cause mortality in TAVI patients as it evaluates RV systolic performance at a given degree of afterload. Incorporation of right-side unit into the risk stratification may improve optimal selection of patients for TAVI.
No takes yet. Share an insight, caveat, or question.
Sultan et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: